San-Marina et al. [23] concluded that the cAMP regulatory element-binding protein (CREB1), a widely expressed transcription factor and a suspected oncogene in AML, was a binding partner for LYL1. The gene discussed is CREB1; the disease is acute myeloid leukemia.